Research progress in radioprotectors from the family of aminothiols
LI Xuejiao TIAN Hongqi
Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Tianjin 300192, China
Abstract：With the development of nuclear technique, the threat of radiation exposure is increasing. As the first generation of radioprotectors, aminothiols can scavenge free radicals formed from ionizing radiation so that they can protect normal tissue from the harmful effects of ionizing radiation. Amifostine is the representative compound among aminothiols and the only small molecular radioprotective agent approved by FDA in clinical application at present, it has good radioprotective effects but many side effects such as hypotension. PrC-210 is a new aminothiol radioprotector, it has few side effects and high radioprotective efficacy. A better aminothiol radioprotectors can be obtained by controlling the number of amino groups in the molecular backbone and molecular weight, and modifying the sulfhydryl group in the molecule.
李雪娇 田红旗. 氨基硫醇类辐射防护剂的研究进展[J]. 中国医药导报, 2019, 16(16): 42-45.
LI Xuejiao TIAN Hongqi. Research progress in radioprotectors from the family of aminothiols. 中国医药导报, 2019, 16(16): 42-45.
[1] Singh VK，Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status：part I. Radiation subsyndromes，animal models and FDA-approved countermeasures [J]. Int J Radiat Biol，2017，93（9）：851-869.
[2] Kleiman NJ，Stewart FA，Hall EJ. Modifiers of radiation effects in the eye [J]. Life Sci Space Res，2017，15：43-54.
[3] Jafari E，Alavi M，Zal F. The evaluation of protective and mitigating effects of vitamin C against side effects induced by radioiodine therapy [J]. Radiat Environ Biophys，2018， 57（3）：233-240.
[4] 张俊伶，路璐，李德冠，等.四种雌激素对放射性造血损伤防护效应的比较[J].中国医药导报，2015，12（10）：4-6，17.
[5] Crowe ME，Lieven CJ，Thompson AF，et al. Borane-protected phosphines are redox-active radioprotective agents for endothelial cells [J]. Redox Biol，2015，6：73-79.
[6] Vasin MV，Ushakov IB，Antipov VV. Potential role of catecholamine response to acute hypoxia in the modification of the effects of radioprotectors [J]. Bull Exp Biol Med，2015，159（5）：597-600.
[7] Vasin MV，Ushakov IB，Kovtun VY，et al. Pharmacological analysis of the therapeutic effect of radioprotectors cystamine and indralin in the capacity of radiomitigators [J]. Bull Exp Biol Med，2017，162（4）：466-469.
[8] Feng M，Smith DE，Normolle DP，et al. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy [J]. Int J Radiat Oncol Biol Phys，2012，83（5）：1441-1447.
[9] Liu W，Chen Q，Wu S，et al. Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage [J]. J Radiat Res，2015，56（2）：278-286.
[10] Rajan Radha R，Chandrasekharan G. Pulmonary injury associated with radiation therapy-Assessment，complications and therapeutic targets [J]. Biomed Pharmacother，2017，89：1092-1104.
[11] Koseva N，Tsacheva I，Mitova V，et al. Polymer complex of WR 2721. Synthesis and radioprotective efficiency [J]. Eur J Pharm Sci，2014，65：9-14.
[12] Rahgoshai S，Mohammadi M，Refahi S，et al. Protective effects of IMOD and cimetidine against radiation-induced cellular damage [J]. J Biomed Phys Eng，2018，8（1）：133-140.
[13] Weiss JF. Pharmacologic approaches to protection against radiation-induced lethality and other damage [J]. Environ Health Perspect，1997，105（S6）：1473-1478.
[14] Kamran MZ，Ranjan A，Kaur N，et al. Radioprotective agents：strategies and translational advances [J]. Med Res Rev，2016，36（3）：461-493.
[15] Peebles DD，Soref CM，Copp RR，et al. ROS-scavenger and radioprotective efficacy of the new PrC-210 aminothiol [J]. Radiat Res，2012，178（1）：57-68.
[16] Soref CM，Hacker TA，Fahl WE. A new orally active，aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses [J]. Int J Radiat Oncol Biol Phys，2012，82（5）：e701-e707.
[17] Copp RR，Peebles DD，Fahl WE. Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors [J]. Bioorg Med Chem Lett，2011，21（24）：7426-7430.
[18] Copp RR，Peebles DD，Soref CM，et al. Radioprotective efficacy and toxicity of a new family of aminothiol analogs [J]. Int J Radiat Biol，2013，89（7）：485-492.
[19] Patyar RR，Patyar S. Role of drugs in the prevention and amelioration of radiation induced toxic effects [J]. Eur J Pharmacol，2018，819：207-216.
[20] Rushworth GF，Megson IL. Existing and potential therapeutic uses for N-acetylcysteine：the need for conversion to intracellular glutathione for antioxidant benefits [J]. Pharmacol Ther，2014，141（2）：150-159.
[21] Kim JK，Park J，Ryu TH，et al. Effect of N-acetyl-L-cysteine on Saccharomyces cerevisiae irradiated with gamma-rays [J]. Chemosphere，2013，92（5）：512-516.
[22] Smith TA，Kirkpatrick DR，Smith S，et al. Radioprotective agents to prevent cellular damage due to ionizing radiation [J]. J Transl Med，2017，15（1）：232-249.
[23] Citrin D，Cotrim AP，Hyodo F，et al. Radioprotectors and mitigators of radiation-induced normal tissue injury [J]. Oncologist，2010，15（4）：360-371.
[24] Vasin MV. Comments on the mechanisms of action of radiation protective agents：basis components and their polyvalence [J]. Springer Plus，2014，3：414.
[25] Maier P，Wenz F，Herskind C. Radioprotection of normal tissue cells [J]. Strahlenther Onkol，2014，190（8）：745-752.
[26] Kim W，Kang J，Lee S，et al. Effects of traditional oriental medicines as anti-cytotoxic agents in radiotherapy [J]. Oncol Lett，2017，13（6）：4593-4601.
2019, Vol. 16 
京公网安备 11010502046598号